Related Experiment Video
Updated: Aug 14, 2026
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
Published on: May 30, 2025
Telomerase activity in esophageal squamous cell carcinoma and lesions unstained with Lugol's solution
Katsuya Yoneyama1, Shigeru Yasumoto, Norio Aoyama
1First Department of Surgery, Yokohama City University School of Medicine, Kanagawa, Japan. fuk1surg@med.yokohama-cu.ac.jp
Background/Aims:
Telomerase is a ribonucleoprotein enzyme that protects erosion of telomeres at the ends of chromosomes and its activity has been detected in immortalized cells and most human cancers.
Methodology:
We analyzed telomerase activity in primary esophageal squamous cell carcinomas (SCCs) without any preoperative treatment and lesions unstained with Lugol's solution, using a telomeric repeat amplification protocol (a TRAP) assay.
Results:
Strong telomerase activities were detected in all resected specimens of esophageal SCCs, and in 33 of 40 endoscopic biopsy specimens of lesions unstained with Lugol's solution. Among lesions unstained with Lugol's solution, 19 of 19 esophageal SCCs, and 13 of 13 dysplasias, which are considered as clinically precancerous lesions had strong telomerase activities.
Conclusions:
These results indicate that reactivation of telomerase may occur at an early stage in the carcinogenesis of esophageal SCCs, and telomerase activity may be a practically useful molecular biological marker for supporting the diagnosis of early esophageal SCCs.
